Definium Therapeutics, Inc. · NASDAQ:DFTX

Roberts Brandi received 125,000 Definium Therapeutics, Inc. shares as an award (Form 4)

Traded Sep 14, 2026 · Filed Sep 14, 2026

On Sep 14, 2026, Roberts Brandi (Chief Financial Officer) received 125,000 Definium Therapeutics, Inc. shares as an award, leaving 397,905 shares. Filed Sep 14, 2026 (Form 4).

Awarded
125,000 shares
Holding after
397,905 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Sep 14, 2026Common SharesAward125,000397,905Direct

Source

View original at SEC

Related